On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...